Alpha-mannosidosis is ultra-rare, but its impact is profound. Delays in diagnosis are all too common, caused by the broad variability of symptoms and their similarity to other pediatric conditions. The AM Learning Zone helps healthcare professionals think rare, recognise early signs, and act faster—transforming outcomes with earlier, more accurate referrals and care.
Behind every learning session is a team of passionate clinicians, researchers, and educators committed to early intervention in Alpha-mannosidosis.
The Alpha-mannosidosis Resource Centre is independently developed and managed by EiP regarding content, topics and speakers appointed. Unrestricted grants and sponsorships are sought to support EIP activities, and Chiesi Farmaceutici S.p.A. has supported EIP's work on the misdiagnosis of metabolic disorders.